Updated:
OptiNose, Inc.
OptiNose, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001494650, and its reported industry is...
Overview
OptiNose, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001494650, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-26, it reported annual revenue of USD 78,226,000; net income of USD -21,541,000; total assets of USD 128,785,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- OptiNose, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Yardley, PA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001494650
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2024USD | $78.2M | -$21.5M | $128.8M | $84.5M | -$44.7M | |
| FY2023USD | $71.0M | -$35.5M | $107.7M | — | -$20.5M | |
| FY2022USD | $76.3M | -$74.8M | $144.2M | — | -$67.7M | |
| FY2021USD | $74.7M | -$82.3M | $166.1M | — | -$76.9M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 10-K/A | FORM-10-K/A | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research OptiNose, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.